These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Synthesis and protective anti-infective action of anomeric lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine]. Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV Bioorg Khim; 2006; 32(4):424-31. PubMed ID: 16909867 [TBL] [Abstract][Full Text] [Related]
3. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine. Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298 [TBL] [Abstract][Full Text] [Related]
4. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons]. Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137 [TBL] [Abstract][Full Text] [Related]
5. [Muramyl dipeptide derivatives in experimental and clinical use]. Kaliuzhin OV Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704 [No Abstract] [Full Text] [Related]
6. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630 [TBL] [Abstract][Full Text] [Related]
7. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
9. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide]. Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005 [TBL] [Abstract][Full Text] [Related]
10. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection. Pouillart PR; Audibert FM; Chedid LA; Lefrancier PL; Bahr GM Int J Immunopharmacol; 1996 Mar; 18(3):183-92. PubMed ID: 8796446 [TBL] [Abstract][Full Text] [Related]
11. [The characteristics of the action of a chemical immunomodulator in a latent viral infection]. Kalenderov AK; Semenova IB Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):87-8. PubMed ID: 8079590 [No Abstract] [Full Text] [Related]
12. Effect of cycloalkyl glycosides of muramyl dipeptide on antibacterial resistance of mice and cytokine production by human mononuclear cells. Kalyuzhin OV; Lobanov DS; Mulik EL; Kimpaeva DS; Zemlyakov AE; Kalina NG; Karaulov AV Bull Exp Biol Med; 2009 Oct; 148(4):623-6. PubMed ID: 20396756 [TBL] [Abstract][Full Text] [Related]
13. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro]. Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897 [TBL] [Abstract][Full Text] [Related]
15. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide]. Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870 [No Abstract] [Full Text] [Related]
16. [The effect of the immunomodulator glucosaminylmuramyl dipeptide on hematopoiesis in mice with experimental cytopenia]. Andrianova IE; Filimonova GI; Andronova TM Radiobiologiia; 1992; 32(4):566-70. PubMed ID: 1410295 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice. Matsumoto K; Ogawa H; Kusama T; Nagase O; Sawaki N; Inage M; Kusumoto S; Shiba T; Azuma I Infect Immun; 1981 May; 32(2):748-58. PubMed ID: 7019079 [TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde. Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563 [TBL] [Abstract][Full Text] [Related]
19. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro]. Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide. Kireszenbaum F; Ferraresi RW Infect Immun; 1979 Jul; 25(1):273-8. PubMed ID: 113344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]